206 related articles for article (PubMed ID: 26303156)
21. Sample size determination for GEE analyses of stepped wedge cluster randomized trials.
Li F; Turner EL; Preisser JS
Biometrics; 2018 Dec; 74(4):1450-1458. PubMed ID: 29921006
[TBL] [Abstract][Full Text] [Related]
22. Sample-size calculations for studies with correlated ordinal outcomes.
Kim HY; Williamson JM; Lyles CM
Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
[TBL] [Abstract][Full Text] [Related]
23. Sample size estimation for repeated measures analysis in randomized clinical trials with missing data.
Lu K; Luo X; Chen PY
Int J Biostat; 2008; 4(1):Article 9. PubMed ID: 22462117
[TBL] [Abstract][Full Text] [Related]
24. Statistical power for analyses of changes in randomized controlled trials.
Tu YK; Blance A; Clerehugh V; Gilthorpe MS
J Dent Res; 2005 Mar; 84(3):283-7. PubMed ID: 15723872
[TBL] [Abstract][Full Text] [Related]
25. Optimal designs in three-level cluster randomized trials with a binary outcome.
Liu J; Liu L; Colditz GA
Stat Med; 2019 Sep; 38(20):3733-3746. PubMed ID: 31162709
[TBL] [Abstract][Full Text] [Related]
26. Two-stage designs for cross-over bioequivalence trials.
Kieser M; Rauch G
Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
[TBL] [Abstract][Full Text] [Related]
27. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
Fazzari MJ; Kim MY; Heo M
J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
[TBL] [Abstract][Full Text] [Related]
28. Split-mouth design in Paediatric Dentistry clinical trials.
Pozos-Guillén A; Chavarría-Bolaños D; Garrocho-Rangel A
Eur J Paediatr Dent; 2017 Mar; 18(1):61-65. PubMed ID: 28494606
[TBL] [Abstract][Full Text] [Related]
29. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
Kennedy-Shaffer L; Hughes MD
Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
[TBL] [Abstract][Full Text] [Related]
30. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
Friede T; Häring DA; Schmidli H
Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
[TBL] [Abstract][Full Text] [Related]
31. The optimal pre-post allocation for randomized clinical trials.
Ma S; Wang T
BMC Med Res Methodol; 2023 Mar; 23(1):72. PubMed ID: 36978004
[TBL] [Abstract][Full Text] [Related]
32. Sample size considerations for matched-pair cluster randomization design with incomplete observations of binary outcomes.
Xu X; Zhu H; Hoang AQ; Ahn C
Stat Med; 2021 Oct; 40(24):5397-5416. PubMed ID: 34245031
[TBL] [Abstract][Full Text] [Related]
33. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
[TBL] [Abstract][Full Text] [Related]
34. The design and analysis of split-mouth studies: what statisticians and clinicians should know.
Lesaffre E; Philstrom B; Needleman I; Worthington H
Stat Med; 2009 Dec; 28(28):3470-82. PubMed ID: 19536744
[TBL] [Abstract][Full Text] [Related]
35. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
van Schie S; Moerbeek M
Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small.
Huang J; Huang J; Chen Y; Ying GS
Ophthalmic Epidemiol; 2018 Feb; 25(1):45-54. PubMed ID: 28891730
[TBL] [Abstract][Full Text] [Related]
37. Power and sample size requirements for GEE analyses of cluster randomized crossover trials.
Li F; Forbes AB; Turner EL; Preisser JS
Stat Med; 2019 Feb; 38(4):636-649. PubMed ID: 30298551
[TBL] [Abstract][Full Text] [Related]
38. Sample size for testing difference between two proportions for the bilateral-sample design.
Qiu SF; Tang NS; Tang ML; Pei YB
J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
[TBL] [Abstract][Full Text] [Related]
39. Inference and sample size calculation for clinical trials with incomplete observations of paired binary outcomes.
Zhang S; Cao J; Ahn C
Stat Med; 2017 Feb; 36(4):581-591. PubMed ID: 27862151
[TBL] [Abstract][Full Text] [Related]
40. Accounting for expected attrition in the planning of community intervention trials.
Taljaard M; Donner A; Klar N
Stat Med; 2007 Jun; 26(13):2615-28. PubMed ID: 17068842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
